114 related articles for article (PubMed ID: 36856143)
21. [Risk factor analysis on body mass rebound after laparoscopic sleeve gastrectomy and establishment of a nomogram prediction model].
Zhao J; Jiao YW; Qian J; Qian ZF; Yang HJ; Tang LM
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Oct; 25(10):913-920. PubMed ID: 36245117
[No Abstract] [Full Text] [Related]
22. Prognostic value of a nomogram based on peripheral blood immune parameters in unresectable hepatocellular carcinoma after intensity-modulated radiotherapy.
Li JX; He ML; Qiu MQ; Yan LY; Long MY; Zhong JH; Zhang RJ; Liang CF; Pang YD; He JK; Chen QQ; Weng JX; Liang SX; Xiang BD
BMC Gastroenterol; 2022 Dec; 22(1):510. PubMed ID: 36494634
[TBL] [Abstract][Full Text] [Related]
23. Predictive factors for survival following stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumour thrombosis and construction of a nomogram.
Li X; Ye Z; Lin S; Pang H
BMC Cancer; 2021 Jun; 21(1):701. PubMed ID: 34126955
[TBL] [Abstract][Full Text] [Related]
24. A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis.
Xing Y; Tian Z; Jiang Y; Guan G; Niu Q; Sun X; Han R; Jing X
Ann Med; 2022 Dec; 54(1):302-309. PubMed ID: 35060835
[TBL] [Abstract][Full Text] [Related]
25. Nomogram Based on Systemic Immune Inflammation Index and Prognostic Nutrition Index Predicts Recurrence of Hepatocellular Carcinoma After Surgery.
Yang J; Bao Y; Chen W; Duan Y; Sun D
Front Oncol; 2020; 10():551668. PubMed ID: 33163397
[TBL] [Abstract][Full Text] [Related]
26. Relationship between the creatinine/cystatin C ratio and muscle mass measured by CT-scan in cancer patients.
Tlemsani C; Durand JP; Raynard B; Revel MP; Deluche E; Di Palma M; Pigneur F; Goldwasser F
Clin Nutr ESPEN; 2022 Oct; 51():412-418. PubMed ID: 36184236
[TBL] [Abstract][Full Text] [Related]
27. Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery.
He K; Si L; Pan X; Sun L; Wang Y; Lu J; Wang X
Front Oncol; 2022; 12():829689. PubMed ID: 35296020
[TBL] [Abstract][Full Text] [Related]
28. Prediction of early recurrence of hepatocellular carcinoma after liver transplantation based on computed tomography radiomics nomogram.
Zhao JW; Shu X; Chen XX; Liu JX; Liu MQ; Ye J; Jiang HJ; Wang GS
Hepatobiliary Pancreat Dis Int; 2022 Dec; 21(6):543-550. PubMed ID: 35705443
[TBL] [Abstract][Full Text] [Related]
29. Dynamic change of the systemic immune inflammation index predicts the prognosis of patients with hepatocellular carcinoma after curative resection.
Wang BL; Tian L; Gao XH; Ma XL; Wu J; Zhang CY; Zhou Y; Guo W; Yang XR
Clin Chem Lab Med; 2016 Dec; 54(12):1963-1969. PubMed ID: 27010778
[TBL] [Abstract][Full Text] [Related]
30. Sarcopenia associates with increased risk of hepatocellular carcinoma among male patients with cirrhosis.
Feng Z; Zhao H; Jiang Y; He Z; Sun X; Rong P; Wang W
Clin Nutr; 2020 Oct; 39(10):3132-3139. PubMed ID: 32057535
[TBL] [Abstract][Full Text] [Related]
31. Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria.
Fu H; Zheng J; Cai J; Zeng K; Yao J; Chen L; Li H; Zhang J; Zhang Y; Zhao H; Yang Y
Cell Physiol Biochem; 2018; 47(1):293-301. PubMed ID: 29768257
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of systemic immune-inflammation index for pathological complete response in patients receiving neoadjuvant immunochemotherapy for locally advanced esophageal cancer.
Han W; Weng K; Zhang P; Hong Z
Front Surg; 2022; 9():1091601. PubMed ID: 36684142
[TBL] [Abstract][Full Text] [Related]
33. A practical nomogram and risk stratification system predicting the cancer-specific survival for patients with early hepatocellular carcinoma.
Yan B; Su BB; Bai DS; Qian JJ; Zhang C; Jin SJ; Jiang GQ
Cancer Med; 2021 Jan; 10(2):496-506. PubMed ID: 33280269
[TBL] [Abstract][Full Text] [Related]
34. Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection.
Yabusaki N; Fujii T; Yamada S; Suzuki K; Sugimoto H; Kanda M; Nakayama G; Koike M; Fujiwara M; Kodera Y
Int J Surg; 2016 Jun; 30():136-42. PubMed ID: 27154615
[TBL] [Abstract][Full Text] [Related]
35. Body Composition Changes in Hepatocellular Carcinoma: Prediction of Survival to Transcatheter Arterial Chemoembolization in Combination With Clinical Prognostic Factors.
Zheng X; Cao F; Qian L; Dong J
Cancer Control; 2021; 28():10732748211038445. PubMed ID: 34569304
[TBL] [Abstract][Full Text] [Related]
36. Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours.
Ding P; Guo H; Sun C; Chen S; Yang P; Tian Y; Lowe S; Zhao Q
Front Nutr; 2022; 9():963265. PubMed ID: 36118766
[TBL] [Abstract][Full Text] [Related]
37. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
[No Abstract] [Full Text] [Related]
38. A nomogram based on combining systemic and hepatic inflammation markers for predicting microscopic bile duct tumour thrombus in hepatocellular carcinoma.
Wu JY; Sun JX; Wu JY; Huang XX; Bai YN; Zeng YY; Zhang ZB; Cheng SQ; Yan ML
BMC Cancer; 2021 Mar; 21(1):272. PubMed ID: 33711965
[TBL] [Abstract][Full Text] [Related]
39. Association Between Sarcopenia and AFP Level in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.
Acosta LF; Galuppo R; García CR; Villacorta E; Dugan A; Castellanos AL; Gedaly R; Lee JT
J Surg Res; 2019 Jun; 238():10-15. PubMed ID: 30721781
[TBL] [Abstract][Full Text] [Related]
40. Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis.
Jeon MY; Lee HW; Kim SU; Heo JY; Han S; Kim BK; Park JY; Kim DY; Ahn SH; Han KH
Hepatol Int; 2017 May; 11(3):268-276. PubMed ID: 28224351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
